Thalys Medical Technology Group Corporation (SHA:603716)

China · Delayed Price · Currency is CNY

17.57

+0.46 (2.69%)

Sep 1, 2026, 3:00 PM CST

SHA:603716 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	836.23	1,077	1,811	2,006	2,309	2,600
Revenue Growth	-41.05%	-40.52%	-9.74%	-13.10%	-11.19%	22.30%
Gross Profit	174.03	229.89	328.54	389.74	448.96	542.74
Operating Income	-79.1	-65.08	7.66	-18.91	-15.51	94.81
Net Income	-199	-207.28	-209.24	-158.57	-153.73	-49.51
Earnings Per Share	-0.94	-1.04	-1.09	-0.82	-0.79	-0.25
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Business	1,035
Industry	41.64
Total	1,077

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	96.22	132.29	209.44	278.59	394.54	485.55
Total Debt	254.23	454.63	924.84	1,050	1,405	1,599
Net Cash (Debt)	-158.01	-322.34	-715.41	-771.26	-1,011	-1,114
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.74	-1.62	-3.73	-3.99	-5.19	-5.62

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	6.63	-37.75	99.6	125.89	28.12	-133.52
Capital Expenditures	-2.84	-5.72	-23.21	-40.83	-54.64	-60.19
Free Cash Flow	3.79	-43.47	76.39	85.06	-26.52	-193.71
Free Cash Flow Growth	-92.02%	-	-10.20%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	20.81%	21.35%	18.14%	19.43%	19.45%	20.88%
Operating Margin	-9.46%	-6.04%	0.42%	-0.94%	-0.67%	3.65%
Pretax Margin	-18.90%	-14.15%	-8.19%	-9.60%	-8.30%	-0.93%
Profit Margin	-23.80%	-19.25%	-11.56%	-7.90%	-6.66%	-1.90%
FCF Margin	0.45%	-4.04%	4.22%	4.24%	-1.15%	-7.45%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	35.82	35.82	35.82	35.82	35.82
P/FCF Ratio	966.47	-	17.68	25.00	-	-
PS Ratio	4.38	3.94	0.75	1.06	0.92	1.08